<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Advaxis, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Advaxis, Inc.

    Advaxis was founded on the vision that no one should suffer from the burdens of cancer. Our goal is to develop cancer immunotherapies that teach the body to recognize tumors as a threat and do so in a way that minimizes side effects associated with traditional chemotherapy and radiation. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Kenneth A. Berlin
    • FOUNDED
      2002
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Second Sight Medical Products, Inc.

    Second Sight Medical Products, Inc.

    The recognized global leader in neuromodulation devices to treat blindness, the co...

    The recognized global leader in neuromodulation...

    Filing Type:    PU
    Caladrius Biosciences, Inc.

    Caladrius Biosciences, Inc.

    Caladrius is a clinical-stage biopharmaceutical company committed to the developme...

    Caladrius is a clinical-stage biopharmaceutical...

    Filing Type:    PU
    Phormed Inc

    Phormed Inc

    PhorMed is a clinical stage biopharmaceutical company located in Beverly Hills Cal...

    PhorMed is a clinical stage biopharmaceutical c...

    Amount Raised:    $128,700.00
    Fundraising Status:    EC
    Filing Type:    CF
    ICON plc

    ICON plc

    Since our foundation in Dublin, Ireland in 1990, our mission has been to help our ...

    Since our foundation in Dublin, Ireland in 1990...

    Filing Type:    PU
    CONMED Corporation

    CONMED Corporation

    CONMED is a medical technology company that provides surgical devices and equipmen...

    CONMED is a medical technology company that pro...

    Filing Type:    PU
    Amarillo Biosciences

    Amarillo Biosciences

    Amarillo Biosciences, Inc. develops biologics for the treatment of human and anima...

    Amarillo Biosciences, Inc. develops biologics f...

    Filing Type:    PU
    Hepion Pharmaceuticals, Inc.

    Hepion Pharmaceuticals, Inc.

    Hepion Pharmaceuticals (Nasdaq: HEPA) is a clinical stage biopharmaceutical compan...

    Hepion Pharmaceuticals (Nasdaq: HEPA) is a clin...

    Filing Type:    PU
    Hutchison China MediTech Limited

    Hutchison China MediTech Limited

    Hutchison China MediTech Limited, known as Chi-Med, is an innovative biopharmaceut...

    Hutchison China MediTech Limited, known as Chi-...

    Filing Type:    PU
    Cortexyme, Inc.

    Cortexyme, Inc.

    Cortexyme is a biopharmaceutical company developing therapeutics based on data sup...

    Cortexyme is a biopharmaceutical company develo...

    Filing Type:    PU
    Aptose Biosciences, Inc.

    Aptose Biosciences, Inc.

    Aptose Biosciences is a clinical-stage biotechnology company developing personaliz...

    Aptose Biosciences is a clinical-stage biotechn...

    Filing Type:    PU
    CohBar, Inc.

    CohBar, Inc.

    CohBar, Inc. is a leader in the research and development of mitochondria based the...

    CohBar, Inc. is a leader in the research and de...

    Filing Type:    PU
    Merrimack Pharmaceuticals, Inc.

    Merrimack Pharmaceuticals, Inc.

    Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is...

    Merrimack is a biopharmaceutical company based ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.